Angelina's choice: private decision, public impact.
Indian J Med Ethics
;
2014 Jan-Mar; 11(1): 34-35
Artigo
em Inglês
| IMSEAR
| ID: sea-153521
ABSTRACT
The decision of the actress, Angelina Jolie (AJ), to undergo preventive risk-reducing bilateral mastectomy has elicited extreme responses, in support and against. We will discuss whether her decision was justified and if there are other options available to women. AJ, who is 38 years old, inherited the BRCA 1 gene. Because of the lack of randomised trials, there is controversy about the overall benefit that various risk-reduction strategies offer carriers of the BRCA 1, but some of the strategies offer a clear benefit. The decision to opt for mastectomy must be driven by the patient's choice, evidence on the balance of the risks and benefits, the quality of life after surgery and issues relating to body image.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Qualidade de Vida
/
Imagem Corporal
/
Neoplasias da Mama
/
Feminino
/
Humanos
/
Comportamento de Escolha
/
Adulto
/
Genes BRCA1
/
Predisposição Genética para Doença
/
Ubiquitina-Proteína Ligases
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Revista:
Indian J Med Ethics
Assunto da revista:
Ethics
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS